Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Biota Pharmaceuticals Inc    NABI

SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Operates as an anti-infective drug development company

Aviragen Therapeutics, Inc. engages in the discovery and development of direct-acting antivirals to treat infections.

Its product candidates include vapendavir, an oral treatment for human rhinovirus infections in moderate-to-severe asthmatics; BTA074, a topical antiviral treatment for genital warts caused by human papillomavirus types 6 & 11; BTA585, an oral fusion protein inhibitor for the treatment of RSV-A and RSV-B infections; and laninamivir octanoate, a one-time, inhaled treatment for influenza A and B infections.

The company was founded on November 8, 2012 and is headquartered in Alpharetta, GA.
Managers
NameAgeSinceTitle
Joseph M. Patti, PhD532012President, CEO & Executive Director
Russell H. Plumb MBA, CPA582012Executive Chairman
Mark P. Colonnese, MBA612015Chief Financial Officer & Executive Vice President
Anna Novotney-Barry-2013Vice President-Clinical Development
John H. Vernachio, PhD-2014Vice President-Preclinical Development
Geoffrey F. Cox, PhD732012Independent Non-Executive Director
Anne M. VanLent692013Lead Independent Non-Executive Director
Michael R. Dougherty592013Independent Non-Executive Director
John P. Richard, MBA592013Independent Non-Executive Director
Armando Anido, MBA592015Independent Non-Executive Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 38,649,237 38,192,309 98.8% 0 0.0% 98.8%
Shareholders
NameEquities%
Broadfin Capital LLC 3,179,226 8.23%
East Hill Management Co. LLC 3,068,358 7.94%
Krensavage Asset Management LLC 2,836,326 7.34%
Senzar Asset Management LLC 1,725,176 4.46%
The Vanguard Group, Inc. 1,078,594 2.79%
Fidelity Management & Research Co. 1,002,500 2.59%
Renaissance Technologies LLC 713,005 1.84%
BlackRock Fund Advisors 574,532 1.49%
Landon Thomas Clay 413,259 1.07%
Stonepine Capital Management LLC 314,421 0.81%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Bio Therapeutic Drugs
Advertisement
Sector Bio Therapeutic Drugs
1st jan.Capitalization (M$)
BIOTA PHARMACEUTICALS ..22
AMGEN17.98%126 856
CELGENE CORPORATION16.03%104 873
GILEAD SCIENCES-1.52%92 150
REGENERON PHARMACEUTIC..40.93%54 987
VERTEX PHARMACEUTICALS81.21%33 251
ACTELION23.36%30 469
GENMAB26.00%13 537
TESARO INC9.10%7 903
EXELIXIS, INC.59.49%6 956
BIOVERATIV INC0.00%6 595
KITE PHARMA INC124.49%5 692
HUALAN BIOLOGICAL ENGI..--.--%4 867
BLUEBIRD BIO INC81.52%4 586
CLOVIS ONCOLOGY INC113.87%4 577
TONGHUA DONGBAO PHARMA..-18.42%4 467
NEUROCRINE BIOSCIENCES..22.35%4 170
PEPTIDREAM INC14.80%3 593
INTERCEPT PHARMACEUTIC..21.76%3 308
JUNO THERAPEUTICS INC53.85%3 077
BIOCON LTD4.68%3 061
Sector Bio Therapeutic Drugs
Biota Pharmaceuticals Inc : Connections
Zygogen LLC
Georgia Venture Partners LLC
Beacon Street Advisors LLC
Phase4 Partners Ltd.
Shire ViroPharma, Inc.
Life Sciences Pennsylvania
Cempra Pharmaceuticals, Inc.
Altiris Therapeutics, Inc.
AMV Advisors
Massachusetts Biotechnology Council
QUE Oncology, Inc.
Lakewood-Amedex, Inc.
International AIDS Vaccine Initiative, Inc.
Altherx, Inc.
Auris Medical AG
Company contact information
Aviragen Therapeutics, Inc.
2500 Northwinds Parkway
Suite 100
Alpharetta, GA 30009

Phone : +1.678.221.3343
Web : www.aviragen.com
© 2017 People , Fundamentals and Ownership